New developments in the antiviral treatment of hepatitis C

被引：10
作者：
de Bruijne, J. [1 ]
Weegink, C. J. [1 ]
Jansen, P. L. M. [1 ]
Reesink, H. W. [1 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, AMC Liver Ctr, NL-1105 AZ Amsterdam, Netherlands
来源：
VOX SANGUINIS | 2009年 / 97卷 / 01期
关键词：
PROTEASE INHIBITOR; PEGINTERFERON ALPHA-2A; INITIAL TREATMENT; VIRAL-HEPATITIS; PLUS RIBAVIRIN; DOUBLE-BLIND; VIRUS; COMBINATION; INTERFERON-ALPHA-2B; EPIDEMIOLOGY;
D O I：
10.1111/j.1423-0410.2009.01187.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Recently, reliable in vitro culture systems have been developed which accelerated antiviral therapy research. Many new specifically targeted antiviral therapies for hepatitis C (STAT-C) and treatment strategies are evaluated in clinical trials. These new antiviral agents are expected to improve treatment significantly with potentially shorter treatment duration. The most promising antiviral agents will be reviewed.
引用
收藏
页码：1 / 12
页数：12
相关论文
共 52 条
  • [41] Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir
    Sarrazin, Christoph
    Kieffer, Tara L.
    Bartels, Doug
    Hanzelka, Brian
    Muh, Ute
    Welker, Martin
    Wincheringer, Dennis
    Zhou, Yi
    Chu, Hui-May
    Lin, Chao
    Weegink, Christine
    Reesink, Henk
    Zeuzem, Stefan
    Kwong, Ann D.
    [J]. GASTROENTEROLOGY, 2007, 132 (05) : 1767 - 1777
  • [42] SCH 503034, a novel hepatitis C virus pro-tease inhibitor, plus pegylated interferon α-2b for genotype 1 nonresponders
    Sarrazin, Christoph
    Rouzier, Regine
    Wagner, Frank
    Forestier, Nicole
    Larrey, Dominique
    Gupta, Samir K.
    Hussain, Musaddeq
    Shah, Amrik
    Cutler, David
    Zhang, Jenny
    Zeuzem, Stefan
    [J]. GASTROENTEROLOGY, 2007, 132 (04) : 1270 - 1278
  • [43] Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV:: Results of a phase 2 randomized study
    Schiano, Thomas D.
    Charlton, Michael
    Younossi, Zobair
    Galun, Eithan
    Pruett, Timothy
    Tur-Kaspa, Ran
    Eren, Rachel
    Dagan, Shlomo
    Graharn, Neil
    Williams, Paulette V.
    Andrews, John
    [J]. LIVER TRANSPLANTATION, 2006, 12 (09) : 1381 - 1389
  • [44] SCHIFF ER, 2008, 41 ANN M EUR ASS STU
  • [45] Natural history of chronic hepatitis C
    Seeff, LB
    [J]. HEPATOLOGY, 2002, 36 (05) : S35 - S46
  • [46] Global epidemiology of hepatitis C virus infection
    Shepard, CW
    Finelli, L
    Alter, M
    [J]. LANCET INFECTIOUS DISEASES, 2005, 5 (09) : 558 - 567
  • [47] Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes
    Simmonds, P
    Bukh, J
    Combet, C
    Deléage, G
    Enomoto, N
    Feinstone, S
    Halfon, P
    Inchauspé, G
    Kuiken, C
    Maertens, G
    Mizokami, M
    Murphy, DG
    Okamoto, H
    Pawlotsky, JM
    Penin, FO
    Sablon, E
    Tadasu, SI
    Stuyver, L
    Thiel, HJ
    Viazov, S
    Weiner, A
    Widell, A
    [J]. HEPATOLOGY, 2005, 42 (04) : 962 - 973
  • [48] Soler M, 2004, ANTIVIR THER, V9, P953
  • [49] STANDRING DN, 2008, 41 ANN M EUR ASS STU
  • [50] Epidemiology of hepatitis C: Geographic differences and temporal trends
    Wasley, A
    Alter, MJ
    [J]. SEMINARS IN LIVER DISEASE, 2000, 20 (01) : 1 - 16
123456